NBIS institutional options flow analysis — multi-leg block trades, dominant direction, and gamma analysis from the public options tape for May 19, 2026. Articles older than 60 days are public; a free account reads back to 30 days, Pro to 5, and AIme Premium reads today's unusual options trades with no delay.

AInvestOption Pilot Program
Unusual FlowDaily DigestNBIS Ticker Page

NBIS Unusual Options Activity — 2026-05-19

Institutional flow on 2026-05-19

Multi-leg block trades, dominant direction, and gamma analysis

$28.0M1 trade
Long Call

Trade Details

BUY$210 CALL20270115$28.0MLong Call

Full Analysis

🐋 NBIS $28M Whale Bet — Someone Just Made a Long-Horizon AI Cloud Call on Nebius

📅 May 19, 2026 | 🔥 Unusual Activity Detected

🎯 The Quick Take

Someone dropped $28 million on a single LEAP call position in Nebius Group (NBIS) this afternoon — 4,300 contracts on the January 15, 2027 $210 strike, with the stock sitting at $199.89. That is fresh money betting NBIS clears $210 before the expiry ≈8 months from now, with two earnings reports and a stack of hyperscaler capacity milestones sitting in between. This is not a hedge — it is a high-conviction, long-horizon bet on one of the fastest-growing AI-infrastructure names on the market.

📊 Company Overview

Nebius Group N.V. (NASDAQ: NBIS) is an AI cloud and GPU-infrastructure company headquartered in the Netherlands, trading on NASDAQ.

💰 The Option Flow Breakdown

📊 The Tape (May 19, 2026 @ 13:50:04)

DateTimeSymbolBuy/SellTypeOCC SymbolExpirationStrikePremiumVolumeOISizeSpotOption Price
2026-05-1913:50:04NBISBUYCALL $210NBIS20270115C2102027-01-15$210$28M4,3006294,300$199.89$66.25

Order Type: BTO — Long Call (fresh open, confirmed)

🤓 What This Actually Means

Let us break down the numbers so they actually make sense:

  • 💸 $28M in premium paid upfront at $66.25 per contract × 4,300 contracts
  • 🐋 Vol/OI ratio of 6.8 — volume is 6.8 times the existing open interest of 629 contracts. This is clearly a fresh opening position, not someone closing out. The market did not have anywhere near this much exposure here before today.
  • 📅 January 15, 2027 expiration — ≈8 months out. This is a LEAP, giving the position time to capture two earnings reports (August 6, 2026 and ≈November 2026) plus multiple hyperscaler capacity ramp milestones.
  • 🎯 $210 strike vs $199.89 spot — the option is ≈5% out of the money right now. The stock needs to trade above $210 before expiry for the position to be in-the-money at expiration. To fully cover the premium paid, the stock would need to reach $210 + $66.25 = ≈$276 by January 15, 2027.
  • 📊 Each contract represents 100 shares. At 4,300 contracts, this controls 430,000 shares of NBIS — worth ≈$86M at current prices. The trader paid $28M in option premium for that exposure, rather than putting up $86M+ to own the shares directly.
  • 🏦 This is institutional money. Your neighbor's Robinhood account does not drop $28M on a single options trade in one fill. Structures like this come from funds, family offices, or large proprietary desks with a specific thesis and a defined time horizon.

Translation for regular folks: Think of it like putting a large deposit down on a piece of real estate, with the right — but not the obligation — to buy it at $210 before next January. You believe the price is heading significantly higher, and you want leveraged upside without risking the full purchase price. The $28M is the deposit. If NBIS rallies hard, the option's value multiplies. If it doesn't clear $210 in a meaningful way, most of that $28M is at risk.

📈 Technical Setup / Chart Check-Up

YTD Performance

NBIS YTD

NBIS has had one of the more dramatic moves of any large-cap on NASDAQ over the past year. The stock ran from a 52-week low of $34.72 all the way to a high of $233.73. Coming into today, it sits at ≈$199.89 — up several hundred percent from its lows and up ≈32% in the five sessions following the May 13, 2026 Q1 earnings beat. The stock has pulled back modestly from its recent high near $233, and today's massive call purchase suggests at least one large buyer sees that pullback as an opportunity rather than a warning sign.

Key observations from the chart:

  • 📈 Parabolic post-earnings re-rate: The Q1 report (684% YoY revenue growth, $399M vs $375M consensus) triggered a sharp upside repricing in mid-May.
  • 🎢 High volatility: This is not a slow-moving mega-cap. NBIS can move 5–10% on a single headline.
  • 📊 The $200 level is pivotal: Current price is essentially sitting on the round-number $200 level, which as we will see from the gamma data below, is where the most significant options-market concentration sits.
  • ⚠️ Still ≈15% below 52-week high ($233.73): The stock has room to recover to prior highs before reaching all-time-high territory, which may be part of the bull thesis here.

Gamma-Based Support & Resistance Analysis

NBIS Gamma S/R

Here is what the gamma exposure (GEX) map tells us about where dealers are positioned and where price tends to gravitate or bounce.

🔵 Support Levels (Put Gamma — Dealers Buy Dips Here):

  • $200 — This is the single most concentrated level in the entire GEX profile, with a total gamma exposure of 5.04 and a net GEX of +2.26 (call gamma dominates here). At ≈0.83% below current price, this is the immediate floor. Market makers holding large positions at $200 will mechanically hedge by buying the underlying as price dips toward this level, creating a cushion.
  • $195 — Secondary support zone at total GEX of 1.60, with net GEX of −0.54 (put gamma heavier here). Dealers would buy stock to offset put delta around this level.
  • $190 — Deeper support, total GEX 2.12, net GEX −0.26. This is a meaningful cluster if $195 breaks.
  • $180 — Extended floor, total GEX 2.24, net GEX −1.04 (put-heavy). A break to this level would represent ≈10% downside from here.
  • $170 — Major put-gamma wall, total GEX 2.44, net GEX −1.34. This would likely only come into play on a significant sentiment shift.

🟠 Resistance Levels (Call Gamma — Dealers Sell Rallies Here):

  • $220 — Nearest meaningful call-gamma concentration above price, total GEX 3.10, net GEX +0.52. Dealers will sell into strength as price approaches $220, creating a natural speed bump.
  • $230 — Next resistance cluster, total GEX 1.71, net GEX +0.71 (call-heavy). Aligns with the area where NBIS recently stalled near its 52-week high.
  • $240 — Total GEX 1.27, net GEX +1.17. A break through $230 and $240 would be technically significant.
  • $250 — Total GEX 1.50, net GEX +1.10. Extended upside target.
  • $260 / $270 / $280 — Lighter call gamma, but still present. Beyond $250, upside momentum could accelerate.

What this means for traders: NBIS is essentially sitting on top of its largest single gamma magnet at $200. This creates a two-sided dynamic: price has a natural floor here because of dealer hedging flows, but it also can become sticky around this level. For the whale's $210 call to have meaningful intrinsic value, the stock needs to clear the $220 resistance cluster first. The $200 wall is currently working as support — a sustained close below $200 would change the near-term technical picture.

Net GEX Bias: Broadly bullish at the $200 strike (call gamma exceeds put gamma), tapering to put-heavy between $190–$197. The $200 level's dominance in the GEX profile explains why the stock has been gravitating here post-earnings.

Implied Move Analysis

NBIS Implied Move

The implied move JSON for today shows timeframes: {} and opex_labels: [] — indicating the structured expiry-by-expiry implied move data was not available at the time of generation. However, we can derive meaningful context from the option price itself:

  • The $210 January 15, 2027 calls were purchased at $66.25. This implies a breakeven price of ≈$276 by expiry.
  • From today's spot of $199.89, that represents a required move of ≈38% to cover the premium in full.
  • Given NBIS's realized volatility profile (the stock went from ≈$35 to ≈$234 in under a year), a 38% move over 8 months is within the range of outcomes this stock has demonstrated — but it is by no means a sure thing.
  • NBIS's NVIDIA relationship and hyperscaler contract momentum (≈$27B Meta deal + ≈$19.4B Microsoft deal) create the kind of large-scale catalyst that could drive that move — but the stock also carries the volatility to move sharply in either direction.

🎪 Catalysts

🔥 Recent Catalysts (Already Happened)

Q1 2026 Earnings Beat — May 13, 2026

Nebius reported Q1 2026 revenue of $399.0M, up 684% year-over-year, beating the $375M consensus by ≈6%. Adjusted EPS of −$0.23 smashed the −$0.77 consensus estimate. Adjusted EBITDA turned positive to $129.5M. The company reaffirmed full-year 2026 guidance of $3.0B–$3.4B revenue and raised capex guidance to $20B–$25B in response to pre-committed 2027 customer demand. The stock ripped ≈32% in the five trading sessions after the report.

Meta ≈$27B Agreement — March 16, 2026

Nebius signed a five-year AI infrastructure agreement with Meta worth ≈$27B — $12B of dedicated capacity leveraging one of the first large-scale NVIDIA Vera Rubin deployments, plus up to $15B of additional committed compute over five years. The contract value at announcement exceeded Nebius's then-total market cap. Official terms via the Nebius newsroom.

Microsoft ≈$19.4B Deal — September 8, 2025

Nebius secured a deal with Microsoft worth ≈$17.4B through 2031, expandable to ≈$19.4B if options are exercised, built around dedicated capacity at the Vineland, New Jersey data center.

NVIDIA Investment and Exemplar Cloud Status

NVIDIA made a ≈$2B equity investment in Nebius and granted it "NVIDIA Exemplar Cloud" status, providing privileged hardware access and priority allocation for next-generation GPU and CPU SKUs, including Vera Rubin. This is a meaningful competitive moat — not every cloud provider gets early access to the newest NVIDIA silicon.

🚀 Upcoming Catalysts (Before / Around January 15, 2027 Expiry)

Q2 2026 Earnings — Estimated August 6, 2026 (Before Market Open)

This is the first major earnings test after the Q1 blowout. Single Q2 consensus EPS estimate: −$0.59. The market will be watching sequential ARR progression toward the $7–9B year-end target, AI-cloud EBITDA margin (Q1 was ≈45%), capex execution against the raised $20–25B guide, and initial revenue recognition from Meta and Microsoft capacity deliveries.

Q3 2026 Earnings — Estimated Early-to-Mid November 2026

This is the last reported quarter before the January 15, 2027 option expiry, making it arguably the single most important pre-expiry catalyst for this trade. Any acceleration or deceleration in ARR growth, margin trajectory, or hyperscaler ramp will be visible here. Historical pattern via MarketBeat.

Meta Vera Rubin Deployment Progress

The first large-scale NVIDIA Vera Rubin cluster build-out under the ≈$27B Meta deal is a key story point for H2 2026. Progress milestones are expected to be disclosed on the August and November earnings calls. Successful ramp is a bull catalyst; delays or scope changes are the primary risk.

Microsoft Vineland Capacity Ramp

Dedicated capacity deliveries scaling through 2026 under the ≈$17.4–19.4B Microsoft agreement. Revenue inflection should be visible in Q2/Q3 prints.

Power and Data-Center Milestones

Management guided to ">4GW of contracted power by year-end 2026". Pennsylvania site (up to 1.2GW secured, targeting 250–300MW by end-2027) and Missouri gigawatt-scale groundbreaking are progress markers to watch.

Stake Monetization Optionality

Nebius holds ≈28% of ClickHouse at an implied ≈$4.2B stake value, ≈83% of Avride at ≈$2.2–2.3B, and a majority economic interest in Toloka at ≈$400–500M. Any up-round, secondary transaction, or IPO process headline for these assets crystallizes hidden value before expiry. Analyst IPO projections center on ≈2028, but interim funding rounds can re-rate the sum-of-the-parts significantly.

Analyst Targets Post-Q1

🎲 Price Targets & Probabilities

Using the gamma levels above, the catalyst calendar, and the implied volatility profile of a stock that has demonstrated a 500%+ move over the past year:

📈 Bull Case (30% probability)

Target: $260–$287 (Citi target) by January 15, 2027

How we get there:

  • 💪 Q2 and Q3 earnings show ARR tracking toward the high end of the $7–9B full-year exit target
  • 🚀 Meta Vera Rubin cluster begins revenue recognition on schedule, announced in August earnings call
  • 🤖 Microsoft Vineland deliveries contribute meaningfully to Q3 revenue
  • 📊 AI-cloud EBITDA margins hold ≈45% or expand, validating the operating leverage thesis
  • ✅ One or more ClickHouse / Avride funding rounds crystallize sum-of-the-parts value
  • 📈 Break through $220 gamma resistance, then $230 (52-week-high area), opens path to $250–$287

Whale's P&L in this scenario: At $276 (the breakeven), the calls are worth ≈$66.25. At $287 (Citi target), intrinsic value is ≈$77 — that is ≈$10.75 above cost, or roughly $46M profit on the $28M investment. At $300, intrinsic value ≈$90, profit ≈$103M.

🎯 Base Case (45% probability)

Target: $200–$235 range (choppy consolidation)

Most likely near-term outcome:

  • ✅ Q2 earnings are solid but do not re-rate the stock sharply above the post-Q1 pop
  • ⚖️ Capex burn ($20–25B guide) and dilution concerns keep a lid on enthusiasm
  • 🔄 Stock oscillates between the $200 gamma magnet floor and the $220–$230 call-gamma resistance band
  • 📊 The $200 gamma wall functions as it should — dealers buy dips, slowing declines
  • ⏰ Real catalyst for a move above $230 likely requires the Q3 report or a major capacity announcement

Whale's P&L in this scenario: With NBIS at $215–$230 at January expiry, the $210 calls have intrinsic value of $5–$20. At $66.25 cost, that is still a significant loss on the position. The whale is counting on a move meaningfully above $210.

📉 Bear Case (25% probability)

Target: $160–$190 (test of deeper support levels)

What could go wrong:

  • 😰 Q2 revenue or ARR misses expectations — sequential growth disappoints after the Q1 blowout
  • 💸 Financing overhang weighs: $4.34B convertible notes plus a contemplated ATM of up to 25M Class A shares create perceived dilution pressure
  • 🚨 Meta or Microsoft scope change — any AI-spend reset at either hyperscaler puts the contracted backlog in question
  • 📉 Break below $200 gamma wall → next meaningful support at $190 (GEX 2.12), then $180 (GEX 2.24)
  • 🤖 NVIDIA GPU allocation shifts or export-control changes disrupt the Vera Rubin timeline

Whale's P&L in this scenario: With NBIS below $210 at January expiry, the calls expire worthless or near-worthless. The $28M premium is largely or entirely lost. This is the defined maximum loss.

💡 Trading Ideas

🛡️ Conservative: Stock Position with Defined Downside

Play: Buy shares, set a stop around $185 (just above the extended GEX support at $180)

Why this works:

  • 📊 The $200 gamma magnet provides near-term mechanical support; you are entering near a demonstrated floor
  • 💰 You participate in any upside without the time-decay problem that comes with options
  • 🛡️ A stop near $185 keeps risk to ≈7% from current levels, a manageable drawdown for a stock this volatile
  • ✅ You collect any upside between now and earnings on August 6 without paying elevated options premium

What to watch: Q2 2026 earnings on August 6 is the next major catalyst. Know before you enter whether you want to hold through that binary event.

Risk level: Moderate | Skill level: Beginner-friendly

Entry point to consider: $195–$202 (near gamma support). Stop: ≈$185.

⚖️ Balanced: Shorter-Dated Call Spread (August or October Expiry)

Play: Buy the August or October $200/$220 call spread to capture the next earnings cycle without paying the full $66 single-option premium

Why this works:

  • 🎯 Defined risk — maximum loss is the net debit on the spread
  • 📊 Targets the $200→$220 move (through the nearest gamma resistance level) rather than needing a full $276 breakeven
  • ⏰ August 6 earnings are a clear near-term catalyst; implied volatility should expand into the print, helping long options
  • 💸 A $200/$220 spread costs substantially less than a standalone $210 call, giving better risk/reward on a shorter-horizon bet

Rough economics (indicative, not exact — check current quotes):

  • Pay roughly $15–$20 for the $200 call, collect roughly $8–$12 for the $220 call, net debit ≈$5–$10
  • Max profit ≈$10–$15 per spread if NBIS is above $220 at expiry
  • Max loss = the net debit paid (fully defined)

Risk level: Moderate | Skill level: Intermediate

🚀 Aggressive: Mirror the Whale (Smaller Scale)

Play: Buy the January 15, 2027 $210 calls, scaled to your own risk tolerance

Why this could work:

  • 🐋 You are aligning with a single documented $28M institutional purchase — someone with presumably deep research and a clear thesis paid $66.25 for these
  • 📅 The LEAP structure gives you time for both Q2 (August) and Q3 (November) earnings to materialize, plus any hyperscaler capacity announcements
  • 🚀 If NBIS re-rates toward Citi's $287 target, the calls move from ≈$66 to ≈$77, a gain of ≈16% on the option value. At $250, intrinsic value is $40 — still a loss from $66 cost, but manageable if you sized conservatively.

Serious risks to understand:

  • 💸 You need NBIS to clear ≈$276 just to break even at expiry. That is a ≈38% move from here.
  • ⏰ Theta (time decay) is real. Each week that passes without a move toward $210+ erodes value.
  • 😰 High implied volatility means the option already prices in a wide range of outcomes. You are paying for that optionality.
  • 💀 Maximum loss is 100% of the premium paid. Unlike stock, options can go to zero.

Only try this if: You fully understand that the entire premium is at risk, you can size it as a small percentage of your portfolio (not more than 1–3% of account), and you have a clear plan for when to cut if NBIS moves against you.

Risk level: High | Skill level: Advanced

⚠️ Risk Factors

These are the things that could work against both the whale's trade and any position in NBIS:

  • 💸 Capex and financing overhang: 2026 capex was just raised to $20–25B against ≈$9.3B cash on hand. The company continuously needs external capital. That means $4.34B of convertible notes already outstanding (conversion triggered at ≥130% of conversion price), $2.0B of prefunded warrants, and a possible ATM program of up to 25M Class A shares are all share-count overhangs. Every time they raise money, existing holders get diluted a little more.

  • 🎯 Customer concentration: Nearly all of Nebius's contracted backlog runs through Microsoft and Meta. If either company changes its AI-spending plans, delays build-outs, or reduces scope, the revenue trajectory gets revised downward materially. Meta AI-spend resets have been a real topic in markets — not a made-up risk.

  • 📊 Valuation near 52-week high: The stock is up several hundred percent from its lows and recently printed near $233. Morgan Stanley remains Equal Weight at $144 — well below today's price — a reminder that not everyone at the major banks is buying the growth narrative at current levels.

  • 🤖 NVIDIA supply dependency: Nebius's entire competitive position — Exemplar Cloud status, Vera Rubin priority, privileged allocation — depends on the NVIDIA relationship staying intact and NVIDIA hardware being available. Any allocation shift or new export-control restrictions affecting GPU shipments would directly pressure growth.

  • 📉 Q1 GAAP profit quality: The Q1 "profit" of $621.2M was overwhelmingly driven by a $780.6M non-cash revaluation gain on the ClickHouse stake. Core adjusted net income is still negative. The company is profitable at the EBITDA level (≈45% margin in AI cloud) but is not generating GAAP earnings from operations. Worth keeping in mind when evaluating how "cheap" or "expensive" the stock is on earnings-based metrics.

  • 🎢 Volatility cuts both ways: NBIS went from $35 to $234 in about a year. It can also give back large chunks of that move quickly. The ≈32% post-earnings pop in five sessions is the same engine that could unwind 20% in a few bad days on a guidance miss or a hyperscaler headline.

  • ⏰ Time decay on the option: For those considering the LEAP calls, every day that passes without NBIS moving toward $210 costs money. The $66.25 premium includes a significant time-value component. Even if the fundamental thesis is correct but the timing is slow, the option can still lose substantial value.

🎯 The Bottom Line

Real talk: This is a well-researched, long-horizon institutional bet — not a casino play. The buyer of 4,300 January 2027 $210 calls paid $28M in a single print, Vol/OI of 6.8 confirms it is entirely fresh open interest, and the structure of the trade (8 months out, ≈5% OTM, LEAP) tells you this person is comfortable holding through multiple earnings cycles and hyperscaler ramp milestones. They are not chasing a weekly catalyst. They are making a calculated statement that Nebius's contracted backlog and NVIDIA-privileged infrastructure position will push this stock meaningfully above $210 between now and January.

What the trade tells us:

  • 🎯 The buyer expects NBIS to clear $210 before January 15, 2027 — and likely substantially above that to justify the premium
  • 📅 Two earnings events (August 6 and ≈November 2026) sit inside the expiry window; the buyer is comfortable with that binary risk
  • 🐋 This is not hedging. A hedge of a short position would look different structurally. This is outright bullish conviction.
  • 📊 The $66.25 premium on a stock at $199.89 implies the market prices significant upside potential for NBIS — and somebody just bet $28M agreeing with that

If you own NBIS:

  • ✅ The $200 gamma wall is your near-term floor. A close below $200 on volume would change the short-term picture.
  • 📅 August 6 is your next major decision point. The Q2 report will tell you whether Q1's 684% growth was a one-off post-contract-signing pop or the beginning of a sustained acceleration.
  • ⚠️ If you are sitting on large gains from below $100, it is entirely reasonable to trim some position ahead of earnings rather than riding the full swing.

If you are watching from the sidelines:

  • 🎯 The $195–$202 range, near the $200 gamma magnet, has been acting as a support zone. That is a more considered entry area than chasing today's print.
  • ⏰ Mark your calendar: August 6, 2026 — Q2 earnings before market open. This is the first real test of whether the post-Q1 re-rate is justified.
  • 📈 Looking for confirmation of: sequential ARR growth tracking toward $7B+ by year-end, Meta Vera Rubin deployment on schedule, AI-cloud EBITDA margins holding ≈45%+, and capex execution without further unexpected dilution.

If you are skeptical:

  • 📊 Morgan Stanley's $144 Equal Weight is the clearest major-bank bear case. Their argument centers on the gap between contracted revenue recognition and the current valuation.
  • 💸 A break below $195–$190 (below the $200 gamma wall) with sustained selling pressure would be a technical signal to step aside.
  • ⚠️ Short-selling a high-growth name with $46B+ in contracted backlog and NVIDIA backing is high-risk. Put spreads with defined risk are a safer way to express skepticism.

Key dates:

  • 📅 August 6, 2026 (before market open) — Q2 2026 earnings. The most important near-term catalyst for this trade.
  • 📅 Early-to-mid November 2026 — Q3 2026 earnings. The last reported quarter before the January 15, 2027 option expiry.
  • 📅 January 15, 2027 — Expiry of the NBIS20270115C210 position. Breakeven at ≈$276; maximum loss = $28M if NBIS is at or below $210.
  • 📅 Year-end 2026 — Nebius management's target for ">4GW contracted power" and $7–9B ARR. Progress checkpoints along the way.

Final verdict: The fundamental story at Nebius is real — 684% year-over-year revenue growth, a ≈$46B contracted backlog from Meta and Microsoft, NVIDIA's own money and brand endorsement, and a sum-of-the-parts in subsidiary stakes that many analysts have not fully valued. Someone just put $28M on that story continuing through January 2027. The risks — dilution, capex burn, customer concentration, valuation near highs — are real and should not be ignored. But this is not a random speculative punt. It is a structured bet by institutional money on a company that has genuinely delivered, with two more earnings reports ahead to either confirm or refute the thesis.

Watch $200 as your key near-term level. Watch August 6 as your key near-term date. Everything else follows from those two data points.

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational and informational purposes only and is not financial advice. Past performance does not guarantee future results. The analysis of unusual options activity does not imply the trade will be profitable or that you should replicate it. The Jan 2027 $210 calls have a maximum loss equal to 100% of premium paid. NBIS is a high-volatility stock; position sizing relative to account size matters greatly. Always do your own research and consider consulting a licensed financial advisor before trading.

About Nebius Group N.V.: Nebius Group N.V. is an AI cloud and GPU infrastructure company (formerly Yandex N.V.) with a ≈$51.7 billion market cap, listed on NASDAQ under "NBIS." The company operates GPU-as-a-service clusters for AI training and inference under a Netherlands domicile, with NVIDIA Exemplar Cloud status and a contracted backlog totaling ≈$46B from Meta and Microsoft.

The Options Desk tracks the move options price into every US earnings report the week of Sep 7, next to how much each stock has actually moved on its past prints — plus the SPY, QQQ and IWM expected ranges and the gamma walls that box them in.